Genes upregulated in cluster 2 are involved in interferon γ signaling, TNF α, and allograft rejection, suggesting an immunomodulatory role for iloprost, as has been shown in mouse models of pulmonary hypertension and lung carcinoma (28–30). This evidence concerns the gene TNF and lung carcinoma.